Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Progression‐free survival of patients harboring BRAF, ERBB2, MET, RET or ROS1 treated with palliative first‐line platinum‐based chemotherapy. The median PFS of patients with each mutation was 10.9 months (95% CI: 1.3–20.5) in BRAF, 5.3 months (95% CI: 3.0–7.5) in ERBB2, 7.2 months (95% CI: 3.6–10.9) in MET, 11.4 months in RET (95% CI: 9.2–13.6), and 10.0 months (95% CI: 3.7–16.4) in ROS1 (p = 0.041). PFS, progression‐free survival
